Literature DB >> 12492813

Class II transactivator-induced expression of HLA-DO(beta) in HeLa cells.

H Khalil1, F Deshaies, A Bellemare-Pelletier, A Brunet, A Faubert, G A Azar, J Thibodeau.   

Abstract

HLA-DO is an intracellular nonclassical MHC class II molecule expressed in the endocytic pathway of B lymphocytes. It shapes the repertoire of peptides bound to classical class II molecules such as HLA-DR by regulating the activity of HLA-DM. Using a peptide corresponding to the cytoplasmic tail of HLA-DO(beta), we have developed a mouse monoclonal antibody, HKC5. Immunofluorescence microscopy revealed that HKC5 recognizes HLA-DO molecules present in the endoplasmic reticulum as well as those in vesicular compartments of the endocytic pathway. In addition, the antibody detects the isolated beta chain on Western blots. Using mutants of the DO(beta) cytoplasmic tail fused to a reporter molecule and expressed in epithelial cells, we showed by flow cytometry that the antibody epitope includes one or both of the leucine residues forming the lysosomal sorting signal. Finally, we have used HKC5 to evaluate the presence of the HLA-DO(beta) chain in HeLa cells expressing the class II transactivator protein CIITA. Our flow cytometry and confocal microscopy analyses showed a marked expression of DO(beta) suggesting that HLA-DO could accumulate under the influence of CIITA in non-B cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12492813     DOI: 10.1034/j.1399-0039.2002.600504.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  9 in total

1.  Role of Sug1, a 19S proteasome ATPase, in the transcription of MHC I and the atypical MHC II molecules, HLA-DM and HLA-DO.

Authors:  Yaritza Inostroza-Nieves; Prasanna Venkatraman; Zarixia Zavala-Ruiz
Journal:  Immunol Lett       Date:  2012-07-04       Impact factor: 3.685

2.  A point mutation in the groove of HLA-DO allows egress from the endoplasmic reticulum independent of HLA-DM.

Authors:  Francis Deshaies; Alexandre Brunet; Djibril A Diallo; Lisa K Denzin; Angela Samaan; Jacques Thibodeau
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-22       Impact factor: 11.205

3.  Disruption of HLA class II antigen presentation in Burkitt lymphoma: implication of a 47,000 MW acid labile protein in CD4+ T-cell recognition.

Authors:  Jason M God; Dan Zhao; Christine A Cameron; Shereen Amria; Jennifer R Bethard; Azizul Haque
Journal:  Immunology       Date:  2014-07       Impact factor: 7.397

4.  Tollip-induced down-regulation of MARCH1.

Authors:  Marie-Claude Bourgeois-Daigneault; Abdul Mohammad Pezeshki; Tristan Galbas; Mathieu Houde; Martin Baril; Klaus Früh; Abdelaziz Amrani; Satoshi Ishido; Daniel Lamarre; Jacques Thibodeau
Journal:  Results Immunol       Date:  2013-02-20

5.  Neutralizing Antibody Responses to Viral Infections Are Linked to the Non-classical MHC Class II Gene H2-Ob.

Authors:  Lisa K Denzin; Aly A Khan; Francesca Virdis; Jessica Wilks; Melissa Kane; Helen A Beilinson; Stanislav Dikiy; Laure K Case; Derry Roopenian; Michele Witkowski; Alexander V Chervonsky; Tatyana V Golovkina
Journal:  Immunity       Date:  2017-08-15       Impact factor: 31.745

6.  Human Hepatitis B Viral Infection Outcomes Are Linked to Naturally Occurring Variants of HLA-DOA That Have Altered Function.

Authors:  Austin M Graves; Francesca Virdis; Eliot Morrison; Miguel Álvaro-Benito; Aly A Khan; Christian Freund; Tatyana V Golovkina; Lisa K Denzin
Journal:  J Immunol       Date:  2020-07-20       Impact factor: 5.422

7.  Evidence for a human leucocyte antigen-DM-induced structural change in human leucocyte antigen-DObeta.

Authors:  Francis Deshaies; Djibril A Diallo; Jean-Simon Fortin; Helen M O'Rourke; Abdul Mohammad Pezeshki; Angélique Bellemare-Pelletier; Nicola Raby; Nathalie Bédard; Alexandre Brunet; Lisa K Denzin; Jacques Thibodeau
Journal:  Immunology       Date:  2008-11-14       Impact factor: 7.397

8.  Burkitt lymphoma: pathogenesis and immune evasion.

Authors:  Jason M God; Azizul Haque
Journal:  J Oncol       Date:  2010-10-05       Impact factor: 4.375

9.  HLA class II defects in Burkitt lymphoma: bryostatin-1-induced 17 kDa protein restores CD4+ T-cell recognition.

Authors:  Azim Hossain; Jason M God; Faisal F Y Radwan; Shereen Amria; Dan Zhao; Jennifer R Bethard; Azizul Haque
Journal:  Clin Dev Immunol       Date:  2011-11-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.